Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID EXTEND Pilot Study
NCT03224923Phase 4Terminated
- Sponsor
- University of Ottawa Heart Institute
- Start
- Aug 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in stable coronary syndrome (SCS), myocardial infarction (MI), sponsored by University of Ottawa Heart Institute. Started Aug 2017; status: terminated.
02
Drugs
ticagrelor
03
Conditions
stable coronary syndrome (SCS)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03224923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03224923.